Peak6 »

Arcutis Biotherapeutics shares owned by Peak6

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Peak6 from 13F filings

Historical chart of Peak6 investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Peak6 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Peak6

Quarter filed Position value Share count Share price at filing
2025-06-30 $140k 10k 14.02
2025-03-31 $156k 10k 15.64
2024-12-31 $279k 20k 13.93

More positions owned by Peak6

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Coreweave Com Cl A Call Option (CRWV)
Apple Call Option (AAPL)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New Call Option (MSTR)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Broadcom Call Option (AVGO)

View all positions for Peak6

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics